ArticleFrontiers in oncology2026

Adaptive dosing of immunotherapy plus anti-angiogenic therapy in a nonagenarian with hepatocellular carcinoma: a case report with 10-year survival.

Pengfei Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.